TrialInternational journal of cancer2025

Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double-blind, randomized controlled DHA-WIN trial.

Jaqueline Munhoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.